Dr. Johnson on Promise of Combination Therapy in Melanoma
3 Visninger
administrator
07/30/23
Douglas B. Johnson, MD, assistant professor of medicine, Vanderbilt University Medical Center, clinical director, Melanoma Research Program, Vanderbilt-Ingram Cancer Center, discusses the promise of combination therapy in patients with melanoma.
Vis mere
Facebook kommentarer
Ingen kommentarer fundet